Sung Young-sook, chairwoman of Hanmi Pharmaceutical Group, said in her New Year's message posted on the company intranet on ...

A year-long management dispute within the Hanmi Pharmaceutical Group family is nearing resolution. The conflict began in ...

Shin Dong-guk invests 1.4 trillion won to resolve Hanmi Pharmaceutical dispute Shin Dong-guks hefty investment raises ...

HCP-1803 is under clinical development by Hanmi Pharmaceuticals and currently in Phase III for Idiopathic (Essential) Hypertension. According to GlobalData, Phase III drugs for Idiopathic (Essential) ...

Poseltinib is under clinical development by Hanmi Pharmaceuticals and currently in Phase II for Autoimmune Disorders. According to GlobalData, Phase II drugs for Autoimmune Disorders have a 35% phase ...

Aaaaaa Aaaaaa Aaaa 447.17 +21.93% ...

Founded in 1935 by Khwaja Abdul Ahmeid, Cipla operates through two segments: Pharmaceuticals and New Ventures. Cipla Limited specialises in developing medications, primarily treating respiratory ...

Merck & Co. Inc. has turned to Asia for a second time to get into the GLP-1 market, this time to Shanghai-based Hansoh Pharmaceutical Group Co. Ltd. for its investigational preclinical oral ...

India has been traditionally quite strong in the pharma sector, with a low cost of manufacturing (30%–35% lower than in the US and Europe), cost-efficient R&D (about 87% less than in developed markets ...

India is set to strengthen its pharmaceutical and healthcare sectors. The government is launching production-linked incentives and building bulk drug parks. These initiatives aim to boost domestic ...

A team of researchers at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) has now developed a groundbreaking genetic method that leverages a natural bacterial mechanism for the ...